HANLIM PHARM is a Manufacturer/Innovator company operating in the pharmaceutical industry.
With the corporate mission of Protecting the Precious Human Life from Various Forms of Diseases , HANLIM has consistently endeavored to improve the health standard of people since its establishment in 1974. And with your warm encouragements, we have grown to become a leading pharmaceutical company in the ethical drug market specialized in IMDs and Ophthalmic Products in Korea. Since 1993 we have been approved KGMP by KFDA, 2012 we have been selected as Innovative Pharmaceutical Company by MOH, 2016 we have been approved PIC/s GMP by MFDS.
Company type
Manufacturer/Innovator
Products and services
Finished Dosage Forms, APIs (Active Pharmaceutical Ingredients)
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Address
HANLIM PHARM, 42, SEOCHO-DAERO 52-GIL, SEOCHO-GU, Seoul, Korea, Republic of, 6634
